Viewing Study NCT06526104


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-03-15 @ 9:17 PM
Study NCT ID: NCT06526104
Status: RECRUITING
Last Update Posted: 2024-12-09
First Post: 2024-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas with Child-Pugh-B Cirrhosis
Sponsor:
Organization: